“Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial”, J of Skin, vol. 7, no. 6, p. s255, Nov. 2023, doi: 10.25251/skin.7.supp.255.